Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients
about
Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cellsThrombospondin-1 and transforming growth factor beta are pro-inflammatory molecules in rheumatoid arthritisCD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimerCytokines as new treatment targets in chronic heart failureChronic Low-Grade Inflammation in Childhood Obesity Is Associated with Decreased IL-10 Expression by Monocyte SubsetsImpaired lipid levels and inflammatory response in rats exposed to cadmiumCD36 deficiency leads to choroidal involution via COX2 down-regulation in rodentsInhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosisCD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress.CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury.CD36-mediated hematoma absorption following intracerebral hemorrhage: negative regulation by TLR4 signaling.CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria.Low levels of CD36 in peripheral blood monocytes in subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study in a Mexican population.PKCδ-IRAK1 axis regulates oxidized LDL-induced IL-1β production in monocytes.Increased CD36 expression signals monocyte activation among patients with type 2 diabetes.CD36 participates in PrP(106-126)-induced activation of microglia.Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.Scavenger receptor CD36 expression contributes to adipose tissue inflammation and cell death in diet-induced obesityVav family Rho guanine nucleotide exchange factors regulate CD36-mediated macrophage foam cell formation.OxLDL or TLR2-induced cytokine response is enhanced by oxLDL-independent novel domain on mouse CD36Immunomodulating therapy: new treatment modality in congestive heart failure.Thrombospondin-1: multiple paths to inflammation.Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke.The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaquesA CD36-dependent signaling cascade is necessary for macrophage foam cell formation.Inflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival CellsThe influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular disease.Insulin promotes macrophage foam cell formation: potential implications in diabetes-related atherosclerosisCD36 as a therapeutic target for endothelial dysfunction in stroke.Viral Inhibition of Bacterial Phagocytosis by Human Macrophages: Redundant Role of CD36.Cytokines and cardiovascular disease.Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications.Systemic inflammation in heart failure--the whys and wherefores.Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retentionTranslational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease.Overexpression of NF-κB p65 in macrophages ameliorates atherosclerosis in apoE-knockout mice3,4-Dihydroxytoluene, a metabolite of rutin, inhibits inflammatory responses in lipopolysaccharide-activated macrophages by reducing the activation of NF-κB signaling.Targets for immunomodulation in cardiovascular disease--where are we now?
P2860
Q24308708-5A1DEE6C-AFEF-4572-8B53-E0618E679AE5Q24319166-E47911B6-7F31-4C31-8309-EDC58AFEDFE5Q24642646-BEF060BD-2C41-4C0F-B231-73CB8D807872Q24799394-C8556A0C-2A1D-46F1-AE1C-276C74ED6CDBQ28555065-3857BBEA-F21E-4832-96F6-5781D43D434EQ28596181-8651C733-3E39-4B20-ACE0-49EB05D53482Q28755557-8DF201B9-8346-4A8D-8ED8-CB17896797ECQ33597181-F5C83C9A-5422-42D8-A7DB-E9C712647F50Q33609100-C05B55DD-7C66-4E97-BF8D-B86F876CCD72Q33641499-96CC2530-DE15-47F0-9B0A-E1A1E5FB1C84Q33697097-A3688C89-BF40-4C12-8AF9-7E7619B32493Q33724828-DD64AB63-0BAD-4015-BD93-9F3DE2092DEFQ33786117-4DE8C19D-39D3-44B8-8926-512ACEA69E77Q33805096-AE585A3D-D490-46F5-895F-D969E6720E53Q33825045-45DB4107-1DBE-4C70-AE4E-52ECF6A2A334Q34084613-7AD0DFED-C8D4-4F76-8DF5-56DC5E28F4F9Q34146362-FD790688-1DE5-44A1-B067-287735C6B263Q34176669-56489DB9-FA30-4274-954A-18844AC1FFDFQ34277413-25961CBC-0F0C-4440-8239-066BFC9B7B36Q34606111-F50E1B77-BDAF-4363-930A-0A9A540AD0A8Q34803791-8BBE1DAB-785C-479F-AC21-30DBEC773201Q35097101-27C3DDB0-3307-420C-A0A9-F19B13D7234FQ35098885-08FC578F-1578-4B11-A95B-1BBD9078E760Q35185434-D5385B0E-FBDE-4462-AD09-48C517084404Q35685440-CAA98DCC-9668-44ED-9204-F7103D936BE0Q35758193-19828E8C-50BA-4A3A-90CA-08880F38411BQ36074078-3046474C-26D7-4526-907C-F2A4D80E3883Q36117830-8D773D58-0364-4593-8796-13A62A6A9868Q36124082-28682643-BDF4-4818-BB46-1AB04698B456Q36139754-EA87BB0B-6962-4191-9AEF-28A50F4ECF83Q36152709-BE24389D-2D2F-403A-A6FF-E842FDE3D7ECQ36188431-8F125CFD-10DA-4F4D-BD91-EF91CCE46697Q36198484-BDF7C48D-8B12-41FE-A95F-6DC0785AE950Q36526913-9448425C-774F-4A0C-9BB7-107AE1A4463AQ36752124-1356B384-CA6E-4D78-8EFB-E229CB8635A0Q36824150-E81C4114-11E2-4B7A-A36B-5A229E5C1B7FQ37421811-416029AE-7C50-4305-9F8D-912B552AAA7CQ37439775-55A8351E-714A-43A7-A68B-F74931E8A18DQ37509899-27198454-4B7D-4EC4-A2E3-C6FE71D056B3Q37608525-ADDCD3C8-A8B5-481C-8307-847E330B3987
P2860
Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients
description
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im August 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/08/01)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/08/01)
@nl
наукова стаття, опублікована в серпні 2000
@uk
مقالة علمية (نشرت في أغسطس 2000)
@ar
name
Oxidized LDL-induced NF-kappa ...... s from CD36-deficient patients
@ast
Oxidized LDL-induced NF-kappa ...... s from CD36-deficient patients
@en
Oxidized LDL-induced NF-kappa ...... s from CD36-deficient patients
@nl
type
label
Oxidized LDL-induced NF-kappa ...... s from CD36-deficient patients
@ast
Oxidized LDL-induced NF-kappa ...... s from CD36-deficient patients
@en
Oxidized LDL-induced NF-kappa ...... s from CD36-deficient patients
@nl
prefLabel
Oxidized LDL-induced NF-kappa ...... s from CD36-deficient patients
@ast
Oxidized LDL-induced NF-kappa ...... s from CD36-deficient patients
@en
Oxidized LDL-induced NF-kappa ...... s from CD36-deficient patients
@nl
P2093
P3181
P356
P1476
Oxidized LDL-induced NF-kappa ...... s from CD36-deficient patients
@en
P2093
H. Hiraoka
K. Matsumoto
S. Yamashita
Y. Matsuzawa
P304
P3181
P356
10.1161/01.ATV.20.8.1953
P407
P577
2000-08-01T00:00:00Z